SUSQUEHANNA INTERNATIONAL GROUP, LLP - DENALI THERAPEUTICS INC ownership

DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 186 filers reported holding DENALI THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.37 and the average weighting 0.3%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of DENALI THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,285,866
-44.1%
110,803
-20.1%
0.00%
-100.0%
Q2 2023$4,092,800
-53.6%
138,692
-63.8%
0.00%
-50.0%
Q1 2023$8,821,186
+514.1%
382,864
+641.2%
0.00%
Q4 2022$1,436,470
-68.7%
51,653
-65.5%
0.00%
-100.0%
Q3 2022$4,589,000
+254.9%
149,527
+240.4%
0.00%
Q2 2022$1,293,000
-73.3%
43,926
-70.8%
0.00%
Q1 2022$4,836,000
-78.1%
150,318
-69.7%
0.00%
Q4 2021$22,096,000
+263.7%
495,390
+311.5%
0.00%
Q3 2021$6,075,000
+2.7%
120,397
+59.6%
0.00%
Q2 2021$5,916,000
-7.3%
75,425
-32.5%
0.00%
Q1 2021$6,380,000
-79.8%
111,724
-70.4%
0.00%
-100.0%
Q4 2020$31,614,000
+939.3%
377,440
+344.7%
0.00%
Q3 2020$3,042,000
+109.9%
84,883
+41.7%
0.00%
Q2 2020$1,449,000
+57.2%
59,883
+13.8%
0.00%
Q1 2020$922,000
-27.4%
52,624
-27.8%
0.00%
Q4 2019$1,270,000
-58.8%
72,900
-63.8%
0.00%
Q3 2019$3,082,000
-48.1%
201,152
-29.7%
0.00%
Q2 2019$5,944,000
+3012.0%
286,315
+2190.5%
0.00%
Q2 2018$191,00012,5000.00%
Other shareholders
DENALI THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Crestline Management, LP 7,705,039$343,645,00025.68%
Casdin Capital, LLC 1,500,000$66,900,0001.89%
Flagship Pioneering Inc. 2,619,968$116,851,0001.81%
SECTORAL ASSET MANAGEMENT INC 189,600$8,456,0001.27%
Integral Health Asset Management, LLC 100,000$4,460,0001.23%
Temasek Holdings (Private) Ltd 5,369,487$239,479,0000.86%
Goldstream Capital Management Ltd 78,418$3,497,0000.86%
Yiheng Capital Management, L.P. 335,184$14,949,0000.76%
GILDER GAGNON HOWE & CO LLC 2,900,114$129,345,0000.74%
Artal Group S.A. 600,000$26,760,0000.73%
View complete list of DENALI THERAPEUTICS INC shareholders